|
PPP2R2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16406884131948E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.58948418263572E-12 |
| Normal-vs-Stage2 |
2.326300E-02 |
| Normal-vs-Stage3 |
8.312400E-02 |
| Normal-vs-Stage4 |
3.318500E-02 |
| Stage1-vs-Stage2 |
3.030800E-01 |
| Stage1-vs-Stage3 |
2.831700E-02 |
| Stage1-vs-Stage4 |
7.299600E-01 |
| Stage2-vs-Stage3 |
4.881800E-01 |
| Stage2-vs-Stage4 |
7.250800E-01 |
| Stage3-vs-Stage4 |
3.490400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.46345174762064E-12 |
| Normal-vs-AfricanAmerican |
5.74500000016798E-07 |
| Normal-vs-Asian |
2.199800E-02 |
| Caucasian-vs-AfricanAmerican |
8.147000E-01 |
| Caucasian-vs-Asian |
4.444600E-01 |
| AfricanAmerican-vs-Asian |
3.722800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-15 |
| Normal-vs-Female |
2.697600E-02 |
| Male-vs-Female |
6.754700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.81329999998847E-06 |
| Normal-vs-Extreme_Weight |
1.82209802801481E-12 |
| Normal-vs-Obese |
7.368500E-04 |
| Normal-vs-Extreme_Obese |
1.197010E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.140200E-01 |
| Normal_Weight-vs-Obese |
3.393000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.907400E-01 |
| Extreme_Weight-vs-Obese |
3.580000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.881200E-01 |
| Obese-vs-Extreme_Obese |
3.178000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.940600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.35539953997011E-10 |
| Normal-vs-Age(61-80Yrs) |
3.99791311167519E-13 |
| Normal-vs-Age(81-100Yrs) |
1.96390004258973E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.732430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.581800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.863600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.255780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.003570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.335800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.415600E-04 |
| Normal-VS-KIRP CIMP |
1.636370E-01 |
| Normal-VS-Unclassified PRCC |
4.31520000000463E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.644000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.795800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.855700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.564200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.981200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.806460E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30499999695388E-08 |
| Normal-vs-N1 |
3.475400E-01 |
| Normal-vs-N2 |
9.377000E-01 |
| N0-vs-N1 |
4.131800E-02 |
| N0-vs-N2 |
5.080200E-02 |
| N1-vs-N2 |
6.570000E-01 |
|
|
